Cargando…
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
[Image: see text] The global pandemic of SARS-CoV-2, the causative viral pathogen of COVID-19, has driven the biomedical community to action—to uncover and develop antiviral interventions. One potential therapeutic approach currently being evaluated in numerous clinical trials is the agent remdesivi...
Autores principales: | Eastman, Richard T., Roth, Jacob S., Brimacombe, Kyle R., Simeonov, Anton, Shen, Min, Patnaik, Samarjit, Hall, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202249/ https://www.ncbi.nlm.nih.gov/pubmed/32483554 http://dx.doi.org/10.1021/acscentsci.0c00489 |
Ejemplares similares
-
Correction to Remdesivir: A Review of Its Discovery
and Development Leading to Human Clinical Trials for Treatment of
COVID-19
por: Eastman, Richard T., et al.
Publicado: (2020) -
Emergency Use Authorization for Remdesivir and Its Potential Implications
por: Ochoa Chaar, Cassius Iyad, et al.
Publicado: (2020) -
Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020) -
Remdesivir for the treatment of COVID-19: author's response
por: Lee, Todd C., et al.
Publicado: (2023) -
Remdesivir use and outcomes during the FDA COVID-19 emergency use
authorization period
por: Elshaboury, Ramy H., et al.
Publicado: (2021)